Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
14%
OVERLAP
BY WEIGHT
9
# OF OVERLAPPING
HOLDINGS
FBT
31
HOLDINGS
30%
ALSO IN CANC
CANC
55
HOLDINGS
16%
ALSO IN FBT
SECTOR DRIFT (FBT minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FBT |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
GENMAB A/S SPONSORED ADR | 3.0% | 3.3% | 3.0% |
 |
AMGEN INC | 3.9% | 2.4% | 2.4% |
|
EXELIXIS INC | 3.4% | 2.3% | 2.3% |
|
BEIGENE LTD. SPONSORED ADR | 3.5% | 2.0% | 2.0% |
|
HALOZYME THERAPEUTICS INC | 3.8% | 1.5% | 1.5% |
FBT Overweight Relative to CANC
|
MODERNA, INC. | 4.2% |
 |
ALKERMES PLC | 3.8% |
|
CORCEPT THERAPEUTICS INC | 3.7% |
 |
BIONTECH SE SPONSORED ADR | 3.6% |
|
VERTEX PHARMACEUTICALS INC | 3.6% |
|
KRYSTAL BIOTECH, INC. | 3.6% |
|
BIOGEN IDEC INC | 3.6% |
|
BIOMARIN PHARMACEUTICAL INC | 3.5% |
|
EXACT SCIENCES CORP | 3.5% |
|
GILEAD SCIENCES INC | 3.5% |
FBT Underweight Relative to CANC
|
REVOLUTION MEDICINES, INC. | -6.1% |
|
BRIDGEBIO PHARMA, INC. | -5.3% |
 |
NOVARTIS AG | -4.9% |
 |
ASTRAZENECA PLC | -4.7% |
|
ELI LILLY & CO | -4.4% |
|
BRISTOL-MYERS SQUIBB CO | -4.3% |
|
ROCHE HOLDINGS LTD-SPONS ADR | -4.1% |
|
MERCK & CO. INC. | -3.9% |
|
NUVALENT, INC. CLASS A | -3.2% |
|
COGENT BIOSCIENCES INC | -3.2% |